ghk-cu copper tripeptide-1 Oral Liposomal GHK GHK-Cu — research peptide |

Injectable AHK-Cu has zero peer-reviewed safety or pharmacokinetic data

Cloudy or gel-like solution: treat it as failed, not ready for accurate research

When pain lasts longer than a week, gets worse, limits your shoulder movement, or comes with swelling, weakness, numbness, or spreading redness, it may be a sign that something more serious happened during or after the injection

The most striking observation from community reports is what is not present: accounts of cancer development following BPC-157 use

It is also compared with KPV and GHK-Cu where inflammation, skin, gut, or connective tissue are part of the discussion